In a bold step to tackle one of the deadliest cancers, Apollo Cancer Centres (ACCs) has unveiled the Lung-Life Screening Program, the first of its kind in India. Lung cancer, often called a silent killer, accounts for 5.9% of all cancers and 8.1% of cancer-related deaths in the country. Yet, the devastating disease is rarely caught early enough to make a difference. That’s where this initiative comes in—to change the story.

Imagine a program designed to find lung cancer before it gets a chance to steal lives. The Lung-Life Screening Program is that game-changer. It uses cutting-edge technology like low-dose computed tomography (LDCT) scans, alongside expert consultations and pulmonary tests, to identify cancer at its earliest, most treatable stage. For those aged 50–80 with a history of smoking, passive smoke exposure, or a family history of lung cancer, this program could be the difference between life and loss.

Globally, the numbers paint a grim picture. According to GLOBOCAN 2020, lung cancer remains the leading cause of cancer-related deaths, claiming 1.8 million lives (18%) in a single year. In India, the battle is even tougher, with 80% of high-risk individuals never having discussed screening with their doctors. This program aims to turn the tide by raising awareness and bringing the conversation into the spotlight.

Dr. Nikhil Modi, Senior Consultant in Pulmonology at Apollo Cancer Centre, explains why early detection is a game-changer. “Lung cancer is one of the deadliest cancers, but catching it early can dramatically improve survival chances. Our Lung-Life Screening Program uses advanced low-dose CT technology, ensuring accurate detection with minimal radiation exposure. It’s about finding the disease early, when we can do the most to help,” he shares.

But this isn’t just about technology—it’s about people and their stories. Dr. Manish Singhal, Senior Consultant in Medical Oncology, believes the initiative is about giving hope. “When we detect lung cancer in its early stages, the chances of effective treatment and recovery skyrocket. This program is about giving patients a fighting chance—using the best tools available to ensure they get the care they deserve,” he says passionately.

And it’s not just the doctors who are excited. Dr. SVS Deo, Lead and Senior Consultant in Surgical Oncology, calls lung cancer a “silent threat” that this program is ready to confront head-on. “By combining precision diagnostics with compassionate care, we’re offering patients a real shot at recovery. It’s proactive healthcare at its finest,” he notes.

This initiative isn’t just a milestone for Apollo Cancer Centres—it’s a revolution for healthcare in India. Shivakumar Pattabhiraman, Managing Director of Indraprastha Apollo Hospitals, puts it perfectly: “The Lung-Life Screening Program is about more than saving lives; it’s about empowering people to take charge of their health. It’s a testament to Apollo’s commitment to leading the fight against cancer.”

At its core, the Lung-Life Screening Program is a promise—a promise to redefine how India tackles lung cancer, one early diagnosis at a time. It’s not just about treating cancer; it’s about giving patients a renewed chance at life and a future filled with hope. Apollo Cancer Centres are lighting the way, proving that with the right tools, conversations, and care, we can make a difference.